Akos Toth's Contact Details

Akos Toth's Company Details

Kedrion Biopharma

, N/A, US • 1000 - 4999 Employees
Major Drugs

Kedrion Biopharma collects and fractionates blood plasma for the development, production and distribution of plasma derivatives used in the treatment of patients suffering from rare and chronic conditions such as hemophilia and immune system deficiencies. A corporation is not a person, but a corporation is run by people and it affects people. And Kedrion's business is people. The very nature of our enterprise is to help people live more full and healthy lives. This commitment extends to how we conduct our business, that is, in ways that are consistent with our mission: to build bridges that benefit people.Long a major player in the plasma derivatives sector in Italy, as partner with the Italian Health System, Kedrion has now become an international participant in the industry with a market presence in 100 countries. We have plants in Italy, Hungary and the United States and plasma collection centers in the US.Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion Biopharma builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.A note about our informational, marketing, and promotional materials. We try to bring our mission, our values, and our work "to life" with stories about "real" people: actual donors, patients, our employees. We have traveled around the world to collect these stories and have had the privilege of meeting extraordinary people generously willing to open and share their lives. We are fortunate to have found a talented and highly regarded photographer; Christian Sinibaldi is responsible for most of the fine photographs you will find in our materials.